Home | Welcome to Contract Pharma   
Last Updated Saturday, April 19 2014
Print

PixarBio Relocates R&D HQ



By Kristin Brooks



Published December 16, 2013
Related Searches: Development R&D
PixarBio Corp. has leased an 8,000-sq.-ft. facility in Medford, MA for its new corporate headquarters and research center, which will house chemical, bio, and tissue labs. The company will move its headquarters in Salem, NH to the new facility in Medford and will now have capacity to expand beyond biomaterials for Parkinson’s disease to include biomaterials for epilepsy.
 
“We are building a home for our world-renowned and award-winning team of researchers to drive innovation and accelerate the development of new treatment options for Parkinson’s disease. We’re confident that our optimized R&D model will generate key intellectual property permitting PixarBio to lead the development of next generation biomaterials for the treatment of Parkinson’s disease as well as a range of chronic neurological conditions,” said chief technology officer Randy Holmes-Farley, Ph.D.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On